| 000 | 01096 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513132539.0 | ||
| 264 | 0 | _c19980123 | |
| 008 | 199801s 0 0 eng d | ||
| 022 | _a1073-6085 | ||
| 024 | 7 |
_a10.1007/BF02752256 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAda, G | |
| 245 | 0 | 0 |
_aOverview of vaccines. _h[electronic resource] |
| 260 |
_bMolecular biotechnology _cOct 1997 |
||
| 300 |
_a123-34 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiotechnology _xmethods |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmune System _xphysiology |
| 650 | 0 | 4 |
_aInfections _ximmunology |
| 650 | 0 | 4 |
_aLymphocytes _xclassification |
| 650 | 0 | 4 |
_aPeptides _xchemistry |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 |
_aVaccines _xclassification |
| 650 | 0 | 4 | _aVaccines, Attenuated |
| 650 | 0 | 4 | _aVaccines, DNA |
| 650 | 0 | 4 | _aVaccines, Inactivated |
| 773 | 0 |
_tMolecular biotechnology _gvol. 8 _gno. 2 _gp. 123-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02752256 _zAvailable from publisher's website |
| 999 |
_c9375785 _d9375785 |
||